2-(tert-Butyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

4,4'-(Ethane-1,2-diylbis(oxy))bis(4-oxobutanoic acid), 98%, 10g

Objetivo de itrio 99,9% dia. 25,4 mm x espesor 3,18 mm 1 ud.

4-t-Butylpyridine-2-carbonitrile, 1g

(S)-3-(Boc-Amino)-4-phenylbutyric acid, 95.0%, 5g

2-METHYL-3,4-DIHYDRO-2H-1,4-BENZOTHIAZINE, 95.0%, 1g

5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-2-methoxypyridine, 95.0%, 250mg

Tamiz molecular 4Å 0.4nm Tipo 514 Forma de perla 250g Envase de vidrio

2-(Trifluoromethylthio)benzaldehyde, 250mg

2,2,4,6,7-Pentamethyl-2,3-dihydrobenzofuran-5-sulfonamide, 95.0%, 5g

4-(3-Bromophenyl)butanoic acid, 95.0%, 100mg

4-Bromo-4'-methoxybiphenyl, 95.0%, 100g

tert-Butyl 2,6-dioxomorpholine-4-carboxylate, 98%, 250mg